Factor Xa Inhibitors Tied to Interstitial Lung Disease in AF

Use of factor Xa inhibitors was associated with a higher risk of interstitial lung disease in Taiwanese patients with nonvalvular atrial fibrillation.

Related Keywords

Italy ,Boston ,Massachusetts ,United States ,Taiwan ,Memorial Hospital ,North Carolina ,Duke University Medical Center ,America ,Linkou Chang Gung ,Jonathan Paul Piccini ,Emanuel Raschi ,Duke Heart Center ,Taiwan National Health Insurance Research Database ,Boston Scientific ,University Of Bologna ,Gregory Lip ,Linkou Chang Gung Memorial Hospital ,Taoyuan City ,Paul Piccini ,North America ,Atrial Fibrillation ,F Atrial Fibrillation ,Thromboembolism ,Interstitial Lung Disease ,Lung ,Factor Xa Inhibitors ,Health Insurance ,Electrophysiology ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,